Option Care Health (OPCH) growth chief awarded 12,678 shares, with tax disposition

Rhea-AI Filing Summary

Option Care Health, Inc. Chief Growth Officer Christopher L. Grashoff reported mixed equity transactions. He received a grant of 12,678 shares of common stock at no cost as part of a restricted stock unit award. According to the footnote, one third of these units vest on each of the first three anniversaries of the grant date. Separately, 259 shares were disposed of at $35.24 per share to cover tax obligations associated with equity compensation, leaving him with 35,880 directly held shares after that tax-withholding transaction and 48,558 shares after the award grant.

Insights

Equity Compensation Analyst

Routine equity grant paired with small tax withholding; net thesis unchanged.

Christopher L. Grashoff, Chief Growth Officer of Option Care Health, Inc., reported a standard compensation event: a grant of 12,678 restricted stock units with three-year, one-third annual vesting. Such awards are typical tools to align executives with long-term shareholder outcomes.

The filing also shows a small disposition of 259 shares at $35.24 per share for tax withholding related to equity compensation, a non-open-market transaction. Combined, these actions modestly increase his overall equity exposure and appear administrative rather than thesis-changing for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grashoff Christopher L.

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Growth Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		F		259	D	$35.24	35,880	D
Common Stock	02/18/2026		A		12,678(1)	A	$0	48,558	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Grashoff	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did OPCH executive Christopher Grashoff report on this Form 4?

Christopher Grashoff reported a grant of 12,678 shares of Option Care Health common stock at no cost and a separate disposition of 259 shares at $35.24 per share to cover tax obligations tied to his equity compensation program.

Was the Option Care Health (OPCH) Form 4 transaction a buy or a sell?

The Form 4 for Option Care Health shows a mixed outcome: an acquisition via a 12,678-share equity grant and a small 259-share disposition specifically for tax withholding, rather than an open-market sale initiated for portfolio or valuation reasons.

How do the new restricted stock units for OPCH’s Chief Growth Officer vest?

The restricted stock units granted to Option Care Health’s Chief Growth Officer vest in three equal installments. One third of the underlying common shares vests on each of the first, second, and third anniversaries of the original grant date, subject to award terms.

How many OPCH shares were used to satisfy tax obligations in this Form 4?

The filing shows that 259 shares of Option Care Health common stock were disposed of at $35.24 per share. This transaction is coded as tax-withholding, meaning the shares were withheld or delivered to satisfy tax liabilities on equity compensation.

Did Christopher Grashoff pay cash for the newly acquired OPCH shares?

No cash purchase occurred for the new shares. The 12,678 shares reported were acquired at a price of $0.00 per share as part of a restricted stock unit grant, reflecting non-cash, stock-based compensation rather than an open-market share purchase.

What does this OPCH Form 4 suggest about insider ownership for the executive?

The Form 4 indicates continued use of equity-based compensation for the executive, with 12,678 new restricted stock units granted and only 259 shares disposed for tax withholding, suggesting a net increase in his overall exposure to Option Care Health common stock.